CV Risk guidelines for Indonesia: What and how to follow? - Renan Sukmawan, MD, Harapan Kita National Cardiovascular Centre, Jakarta-Indonesia

T2DM & CVD: An update on current and new strategies improving outcomes - Neil Poulter, MD, Imperial College London, United Kingdom

Educational information

The overall educational objectives of the Cardiovascular Master Class were to:

review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Russia

review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes

understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.

understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice

Develop a consensus on practical guidelines for day-to-day management of high risk patients

CME accreditation

This Master Class was endorsed and accredited by the Indonesian Cardiology Association

Funding

The CV Risk Master Class was funded by an unrestricted educaional grant provided by Pfizer

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.